FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2039193768> ?p ?o ?g. }

• W2039193768 endingPage "360" @default.
• W2039193768 startingPage "351" @default.
• W2039193768 abstract "Oral antineoplastic drugs, not generally covered by Medicare Part B, have assumed an increasingly important role in cancer treatment.We examined use and spending on infused/injected (Part B covered) and non-Part B antineoplastic agents in a Medicare beneficiary population with cancer, and the effect of supplemental insurance.This retrospective, observational study used pooled 1997-2007 data from the Medicare Current Beneficiary Survey, linked to Medicare claims. Logistic regression models identified factors associated with antineoplastic use. Generalized linear models were used to estimate spending among antineoplastic users.A total of 1836 Medicare beneficiaries with newly diagnosed cancer were selected based on the presence of claims-based diagnoses after a 12-month washout period.Five hundred fifty-nine (31.0%) Medicare beneficiaries received antineoplastic therapy; 395 (21.3%) used Part B, 253 (14.6%) used non-Part B antineoplastics. Spending per user was $7841 (any), $10,364 (Part B), and $1535 for non-Part B antineoplastics. Supplemental insurance was associated with antineoplastic use. Primary cancer site and age were key predictors of spending among users. Spending on non-Part B antineoplastics increased during 2006-2007 relative to 2004-2005 but time trends were not significant in multivariate analysis.Antineoplastic therapy use by Medicare beneficiaries is sensitive to the presence but not type of supplemental insurance. Non-Part B therapy was used by a relatively large proportion of beneficiaries with cancer receiving therapy, although spending was less than for Part B therapy. Monitoring the role of supplemental insurance, and particularly the role of Medicare Part D is a critical area for ongoing research." @default.
• W2039193768 created "2016-06-24" @default.
• W2039193768 creator A5019575613 @default.
• W2039193768 creator A5028657875 @default.
• W2039193768 creator A5034694006 @default.
• W2039193768 creator A5039250756 @default.
• W2039193768 creator A5044130455 @default.
• W2039193768 creator A5058574429 @default.
• W2039193768 creator A5071121583 @default.
• W2039193768 creator A5085920834 @default.
• W2039193768 creator A5086351627 @default.
• W2039193768 date "2013-04-01" @default.
• W2039193768 modified "2023-09-23" @default.
• W2039193768 title "Use and Spending on Antineoplastic Therapy for Medicare Beneficiaries With Cancer" @default.
• W2039193768 cites W1984199268 @default.
• W2039193768 cites W2001584584 @default.
• W2039193768 cites W2032523249 @default.
• W2039193768 cites W2032655930 @default.
• W2039193768 cites W2036482755 @default.
• W2039193768 cites W2050056063 @default.
• W2039193768 cites W2069703793 @default.
• W2039193768 cites W2078072893 @default.
• W2039193768 cites W2083585578 @default.
• W2039193768 cites W2101814490 @default.
• W2039193768 cites W2148135319 @default.
• W2039193768 cites W2308172596 @default.
• W2039193768 cites W2321112275 @default.
• W2039193768 cites W32006757 @default.
• W2039193768 doi "https://doi.org/10.1097/mlr.0b013e3182726ceb" @default.
• W2039193768 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23222498" @default.
• W2039193768 hasPublicationYear "2013" @default.
• W2039193768 type Work @default.
• W2039193768 sameAs 2039193768 @default.
• W2039193768 citedByCount "11" @default.
• W2039193768 countsByYear W20391937682014 @default.
• W2039193768 countsByYear W20391937682015 @default.
• W2039193768 countsByYear W20391937682016 @default.
• W2039193768 countsByYear W20391937682017 @default.
• W2039193768 countsByYear W20391937682018 @default.
• W2039193768 countsByYear W20391937682021 @default.
• W2039193768 countsByYear W20391937682022 @default.
• W2039193768 crossrefType "journal-article" @default.
• W2039193768 hasAuthorship W2039193768A5019575613 @default.
• W2039193768 hasAuthorship W2039193768A5028657875 @default.
• W2039193768 hasAuthorship W2039193768A5034694006 @default.
• W2039193768 hasAuthorship W2039193768A5039250756 @default.
• W2039193768 hasAuthorship W2039193768A5044130455 @default.
• W2039193768 hasAuthorship W2039193768A5058574429 @default.
• W2039193768 hasAuthorship W2039193768A5071121583 @default.
• W2039193768 hasAuthorship W2039193768A5085920834 @default.
• W2039193768 hasAuthorship W2039193768A5086351627 @default.
• W2039193768 hasConcept C10138342 @default.
• W2039193768 hasConcept C121608353 @default.
• W2039193768 hasConcept C126322002 @default.
• W2039193768 hasConcept C144024400 @default.
• W2039193768 hasConcept C144133560 @default.
• W2039193768 hasConcept C145097563 @default.
• W2039193768 hasConcept C149923435 @default.
• W2039193768 hasConcept C151956035 @default.
• W2039193768 hasConcept C23131810 @default.
• W2039193768 hasConcept C2426938 @default.
• W2039193768 hasConcept C26869875 @default.
• W2039193768 hasConcept C2776291444 @default.
• W2039193768 hasConcept C2778858636 @default.
• W2039193768 hasConcept C2908647359 @default.
• W2039193768 hasConcept C2910449239 @default.
• W2039193768 hasConcept C512399662 @default.
• W2039193768 hasConcept C71924100 @default.
• W2039193768 hasConcept C98274493 @default.
• W2039193768 hasConcept C99454951 @default.
• W2039193768 hasConceptScore W2039193768C10138342 @default.
• W2039193768 hasConceptScore W2039193768C121608353 @default.
• W2039193768 hasConceptScore W2039193768C126322002 @default.
• W2039193768 hasConceptScore W2039193768C144024400 @default.
• W2039193768 hasConceptScore W2039193768C144133560 @default.
• W2039193768 hasConceptScore W2039193768C145097563 @default.
• W2039193768 hasConceptScore W2039193768C149923435 @default.
• W2039193768 hasConceptScore W2039193768C151956035 @default.
• W2039193768 hasConceptScore W2039193768C23131810 @default.
• W2039193768 hasConceptScore W2039193768C2426938 @default.
• W2039193768 hasConceptScore W2039193768C26869875 @default.
• W2039193768 hasConceptScore W2039193768C2776291444 @default.
• W2039193768 hasConceptScore W2039193768C2778858636 @default.
• W2039193768 hasConceptScore W2039193768C2908647359 @default.
• W2039193768 hasConceptScore W2039193768C2910449239 @default.
• W2039193768 hasConceptScore W2039193768C512399662 @default.
• W2039193768 hasConceptScore W2039193768C71924100 @default.
• W2039193768 hasConceptScore W2039193768C98274493 @default.
• W2039193768 hasConceptScore W2039193768C99454951 @default.
• W2039193768 hasIssue "4" @default.
• W2039193768 hasLocation W20391937681 @default.
• W2039193768 hasLocation W20391937682 @default.
• W2039193768 hasOpenAccess W2039193768 @default.
• W2039193768 hasPrimaryLocation W20391937681 @default.
• W2039193768 hasRelatedWork W2022079104 @default.
• W2039193768 hasRelatedWork W2042818407 @default.
• W2039193768 hasRelatedWork W2083751751 @default.
• W2039193768 hasRelatedWork W2116437054 @default.

• next